A Patient with Four-Year Survival after Nonsmall Cell Lung Carcinoma with a Solitary Metachronous Small Bowel Metastasis

Por Kant, Klaas M., Noordhoek Hegt, Vincent, Aerts, Joachim G. J. V.
Publicado em 2010

Improving lung cancer survival; time to move on

Por Heuvers, Marlies E, Hegmans, Joost P, Stricker, Bruno H, Aerts, Joachim G
Publicado em 2012

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

Por Aerts, Joachim G., Lievense, Lysanne A., Hoogsteden, Henk C., Hegmans, Joost P.
Publicado no Transl Lung Cancer Res (2014)

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

Por Heuvers, Marlies E, Aerts, Joachim G, Cornelissen, Robin, Groen, Harry, Hoogsteden, Henk C, Hegmans, Joost P
Publicado em 2012

Endoscopic Ultrasound Fine Needle Aspiration in the Diagnosis of Lymphoma

Por Creemers, Koen, van der Heiden, Olaf, Los, Jan, van Esser, Joost, Newhall, David, Djamin, Remco S., Aerts, Joachim G.
Publicado em 2011

Iron deficiency anemia as initial presentation of a non-small cell lung carcinoma: A case report

Por Linsen, Philip V.M., Linsen, Victor M.J., Buunk, Gerba, Arnold, Dorothee E., Aerts, Joachim G.J.V.
Publicado no Respir Med Case Rep (2015)

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

Por Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
Publicado em 2013

Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma

Por Cornelissen, Robin, Lievense, Lysanne A., Maat, Alexander P., Hendriks, Rudi W., Hoogsteden, Henk C., Bogers, Ad J., Hegmans, Joost P., Aerts, Joachim G.
Publicado em 2014

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

Por Ujiie, Hideki, Kadota, Kyuichi, Nitadori, Jun-ichi, Aerts, Joachim G, Woo, Kaitlin M, Sima, Camelia S, Travis, William D, Jones, David R, Krug, Lee M, Adusumilli, Prasad S
Publicado no Oncoimmunology (2015)

Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer

Por Ubels, Rutger J, Mokhles, Sahar, Andrinopoulou, Eleni R, Braat, Cornelia, van der Voort van Zyp, Noëlle C, Aluwini, Shafak, Aerts, Joachim G J V, Nuyttens, Joost J
Publicado no Radiat Oncol (2015)

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Por Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Publicado em 2010

Adherence, exposure and patients’ experiences with the use of erlotinib in non-small cell lung cancer

Por Timmers, Lonneke, Boons, Christel C. L. M., Moes-ten Hove, J., Smit, Egbert F., van de Ven, Peter M., Aerts, Joachim G., Swart, Eleonora L., Boven, Epie, Hugtenburg, Jacqueline G.
Publicado no J Cancer Res Clin Oncol (2015)

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Por Brahmer, Julie, Reckamp, Karen L., Baas, Paul, Crinò, Lucio, Eberhardt, Wilfried E.E., Poddubskaya, Elena, Antonia, Scott, Pluzanski, Adam, Vokes, Everett E., Holgado, Esther, Waterhouse, David, Ready, Neal, Gainor, Justin, Frontera, Osvaldo Arén, Havel, Libor, Steins, Martin, Garassino, Marina C., Aerts, Joachim G., Domine, Manuel, Paz-Ares, Luis, Reck, Martin, Baudelet, Christine, Harbison, Christopher T., Lestini, Brian, Spigel, David R.
Publicado no N Engl J Med (2015)